TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:12
NightHawk Biosciences Inc. ( NHWK ) https://www.nighthawkbio.com
0.33USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-61.31%
NHWK
SPY
30.72%
-94.34%
NHWK
SPY
112.82%
-95.40%
NHWK
SPY
201.04%
-99.94%
NHWK
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
8.47
7.53
0.51
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
0.00
0.00
0.25
-369.03
0.00
-0.20
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-52.55
24.63
-0.59
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.5668
603933273.00
-28.73
1.62
Other Earnings and Cash Flow Stats:
NightHawk Biosciences Inc. ( NHWK ) Net Income TTM ($MM) is 110437.56
NightHawk Biosciences Inc. ( NHWK ) Operating Income TTM ($MM) is -42.91
NightHawk Biosciences Inc. ( NHWK ) Owners' Earnings Annual ($MM) is 0.00
NightHawk Biosciences Inc. ( NHWK ) Current Price to Owners' Earnings ratio is 0.00
NightHawk Biosciences Inc. ( NHWK ) EBITDA TTM ($MM) is -36.19
NightHawk Biosciences Inc. ( NHWK ) EBITDA Margin is -0.59%
Capital Allocation:
NightHawk Biosciences Inc. ( NHWK ) has paid 0.00 dividends per share and bought back -0.437246 million shares in the past 12 months
NightHawk Biosciences Inc. ( NHWK ) has increased its debt by 1.506934 million USD in the last 12 months
Capital Structure:
NightHawk Biosciences Inc. ( NHWK ) Interest-bearing Debt ($MM) as of last quarter is 3
NightHawk Biosciences Inc. ( NHWK ) Annual Working Capital Investments ($MM) are 8
NightHawk Biosciences Inc. ( NHWK ) Book Value ($MM) as of last quarter is 33
NightHawk Biosciences Inc. ( NHWK ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
NightHawk Biosciences Inc. ( NHWK ) has 2 million in cash on hand as of last quarter
NightHawk Biosciences Inc. ( NHWK ) has 24 million of liabilities due within 12 months, and long term debt 0 as of last quarter
NightHawk Biosciences Inc. ( NHWK ) has 26 common shares outstanding as of last quarter
NightHawk Biosciences Inc. ( NHWK ) has 0 million USD of preferred stock value
Academic Scores:
NightHawk Biosciences Inc. ( NHWK ) Altman Z-Score is 84.30 as of last quarter
NightHawk Biosciences Inc. ( NHWK ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
NightHawk Biosciences Inc. ( NHWK ) largest shareholder is owning shares at 0.00 ($MM) value
John K A Prendergast(an insider) Sold 35000 shares of NightHawk Biosciences Inc. ( NHWK ) for the amount of $205450.00 on 2021-05-14
5.14% of NightHawk Biosciences Inc. ( NHWK ) is held by insiders, and 9.24% is held by institutions
NightHawk Biosciences Inc. ( NHWK ) went public on 2013-07-24
Other NightHawk Biosciences Inc. ( NHWK ) financial metrics:
FCF:-50.95
Unlevered Free Cash Flow:0.00
EPS:-2.02
Operating Margin:-52.55
Gross Profit Margin:24.63
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-144.74
Beta:1.62
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About NightHawk Biosciences Inc. ( NHWK ) :
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.